Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide
Authors:
- Randi Y. LeavittRLRandi Y. Leavitt
- Thomas A. FleisherTFThomas A. Fleisher
- James R. MinorJMJames R. Minor
- Anthony S. FauciAFAnthony S. Fauci
- 1 October 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 89 (4) , 403-410
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Stage-adapted treatment of Wegener's granulomatosisJournal of Molecular Medicine, 1989
- Malignancy following treatment of rheumatoid arthritis with cyclophosphamideThe American Journal of Medicine, 1987
- Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells.Journal of Clinical Investigation, 1987
- Effect of Treatment on the Evolution of Renal Abnormalities in Lupus NephritisNew England Journal of Medicine, 1984
- The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.Annals of the Rheumatic Diseases, 1983
- Cyclophosphamide Therapy of Severe Systemic Necrotizing VasculitisNew England Journal of Medicine, 1979
- Selective depletion of Ig‐bearing lymphocytes by cyclophosphamide in rheumatoid arthritis and systemic lupus erythematosu guidelines for dosageArthritis & Rheumatism, 1974
- Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosisArthritis & Rheumatism, 1974
- WEGENERʼS GRANULOMATOSIS: STUDIES IN EIGHTEEN PATIENTS AND A REVIEW OF THE LITERATUREMedicine, 1973
- Giant-cell Granuloma of the Respiratory Tract (Wegener's Granulomatosis)BMJ, 1958